BCYC vs EQIX · rev $1.5M vs P/E 79, rev $5.07B
Bicycle Therapeutics Ltd (BCYC) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
BCYC currently screens at market cap $554.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the BCYC and EQIX stock pages for the full models.
Not investment advice.